Print
Email
Auxilium Pharmaceuticals Inc. has a market cap of $723.07 million; its shares were traded at around $15.08 with and P/S ratio of 3.42.
This is the annual revenues and earnings per share of AUXL over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of AUXL.
CEO Recent Trades:
- CEO & President Armando Anido sold 5,275 shares of AUXL stock on 10/07/2011 at the average price of 14.23. Armando Anido owns at least 147,136 shares after this. The price of the stock has increased by 5.97% since.
- CEO & President Armando Anido sold 5,275 shares of AUXL stock on 07/08/2011 at the average price of 20.3. Armando Anido owns at least 147,136 shares after this. The price of the stock has decreased by 25.71% since.
This is the insider trade history vs. stock price of AUXL. For the complete insider trading history of AUXL, click here.
Directors and Officers Recent Trades:
- 10% Owner / Tisch Capital (gp), Ll Baker sold 8,145 shares of AUXL stock on 08/01/2011 at the average price of 18.04. / Tisch Capital (gp), Ll Baker owns at least 67,322 shares after this. The price of the stock has decreased by 16.41% since.
- 10% Owner Brothers Life Sciences C Baker sold 655,272 shares of AUXL stock on 08/01/2011 at the average price of 18.04. Brothers Life Sciences C Baker owns at least 5,416,304 shares after this. The price of the stock has decreased by 16.41% since.
- 10% Owner Biotech Capital (gp), Ll Baker sold 102,209 shares of AUXL stock on 08/01/2011 at the average price of 18.04. Biotech Capital (gp), Ll Baker owns at least 844,839 shares after this. The price of the stock has decreased by 16.41% since.
- 10% Owner Capital (gp), Llc 14159 sold 16,078 shares of AUXL stock on 08/01/2011 at the average price of 18.04. Capital (gp), Llc 14159 owns at least 132,889 shares after this. The price of the stock has decreased by 16.41% since.
For the complete insider trading history of AUXL, click here.
Subscribe RSS
